Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study.
Mason NL, Szabo A, Kuypers KPC, Mallaroni PA, de la Torre Fornell R, Reckweg JT, Tse DHY, Hutten NRPW, Feilding A, Ramaekers JG
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (0)
No references identified in the available metadata. This does not establish that none exist.
Cited by — these papers cite this paper (8)
- Psilocybin restores behavioral and neuroplastic deficits induced by chronic stress in rats 2026-06-01 · Expand citations
- Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder 2026-05-26 · Expand citations
- Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications 2026-04-01 · Expand citations
- Pilot study of psilocybin in patients with post-treatment lyme disease 2026-02-25 · Expand citations
- Psilocybin exerts differential effects on social behavior and inflammation in mice in contexts of activity-based anorexia 2026-02-03 · Expand citations
- Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathway 2025-10-01 · Expand citations
- Psilocybin and psilocin regulate microglial immunomodulation and support neuroplasticity via serotonergic and AhR signaling 2025-06-01 · Expand citations
- Psilocin, the Psychoactive Metabolite of Psilocybin, Modulates Select Neuroimmune Functions of Microglial Cells in a 5-HT2 Receptor-Dependent Manner 2024-10-28 · Expand citations